|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/43 | |
| A61K 38/48 | |||
| A61K 9/00 | |||
| A61P 13/08 | |||
| A61P 13/10 | |||
| A61P 25/00 |
| (11) | Number of the document | 2117584 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08743476.7 |
| Date of filing the European patent application | 2008-02-14 | |
| (97) | Date of publication of the European application | 2009-11-18 |
| (45) | Date of publication and mention of the grant of the patent | 2013-10-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/053989 |
| Date | 2008-02-14 |
| (87) | Number | WO 2008/101098 |
| Date | 2008-08-21 |
| (30) | Number | Date | Country code |
| 890052 P | 2007-02-15 | US |
| (72) |
BLUMENFELD, Andrew, M., US
GAYLIS, Franklin, David, US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
Gaylis, Franklin David, 8851 Center Drive Suite 501, La Mesa CA 91942, US |
| (54) | USE OF BOTULINUM TOXIN AND ENZYMES FOR TREATING BLADDER DISORDERS |
| USE OF BOTULINUM TOXIN AND ENZYMES FOR TREATING BLADDER DISORDERS |